Table 2.
Characteristics of subjects for studies comparing sarcoidosis and healthy controls
| Figure | Fig 1A and 3B | Fig 1B and 3C | Fig 4A | |||
|---|---|---|---|---|---|---|
| Subjects | S | HC | S | HC | S | HC |
| Total subjects, n | 51 | 25 | 36 | 12 | 18 | 12 |
| Total events | 57 | 25 | 40 | 12 | 18 | 12 |
| Mean age (SD) in years | 49.9 (12.7) | 41.0(11.0) | 48.2(10.6) | 42.0(13.0) | 47.9(8.0) | 35.0(7.0) |
| CXR stage 0/1/2/3/4a | 15/11/15/11/15 | NA | 8/7/11/10/4 | NA | 5/5/3/3/2 | NA |
S, sarcoidosis; HC, healthy controls. NA, not applicable (where there are no controls).
a
Scadding CXR stage: 0 = no adenopathy, no lung infiltrates; stage 1, hilar adenopathy only; stage 2, hilar adenopathy and lung infiltrates; stage 3, lung infiltrates only; stage 4, pulmonary fibrosis. Last row refers number of patients per each Scadding stage. SD, standard deviation.